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In their guest editorial published in
Environmental Health Perspectives, Brown
and Rhoads (2008) endorsed the Centers for
Disease Control and Prevention’s (CDC)
position, maintaining the child blood lead
level (BLL) of concern at the 10-µg/dL 1991
standard (CDC 2008). They added little
substance to support the rationale.
Brown and Rhoads (2008) expressed
surprise that the BLL–IQ relationship
slope at low BLL is steeper than at higher
BLL. Almost all studies examining
BLL–IQ relationships have found this
nonlinear form, as summarized in the
pooled analysis of seven prospective lead
studies (Lanphear et al. 2005). Nonlinear
lead response is also found in child studies
with math and vocabulary scores (Kordas
et al. 2006) and fine motor and visual
motor function (Wasserman et al. 2000),
as well as many others. The authors doubt
this relationship, wondering if “such a
strong relationship is plausible, particu-
larly as there are no directly relevant ani-
mal or in vitro studies that demonstrate”
the relationship (Brown and Rhoads
2008). They are uninformed. To cite just
a few relevant studies, lead inhibits
δ-aminolevulinic acid dehydratase activity
in humans (Murata et al. 2003) and
inhibits peak current amplitude of acetyl-
choline-induced currents in cultured rat
hippocampal neurons (Ishihara et al.
1995); in monkeys, increasing gestational
lead resulted in increasing incomplete
responses during acquisition of a fixed-
ratio operant task (Newland et al. 1996),
all with nonlinear dose response. 
In their editorial, Brown and Rhoads
(2008) hypothesized increased national IQ
from decreased child BLL in the United
States from the late 1970s to 2002 based on
the nonlinear relationship. They claimed,
without citation, that “there is no agree-
ment that IQs have increased by 7 points.”
However, they ignored the Flynn effect
(Flynn 1985)—the secular trend of IQ
increase noted throughout the world.
During the late 1970s–2002, the Wechsler
Intelligence Scale for Children changed in
content and standardization to account for
the Flynn effect, making impossible long-
term national tracking of IQ increase with
this or any renormalized test. Although
Brown and Rhoads (2008) cited no change
in U.S. student reading scores, they failed
to note that mathematics and science scores
in the same longitudinal study increased
significantly from 1982 to 1999 (Campbell
et al. 2000).
Brown and Rhoads (2008) stated in their
editorial that the CDC will not change the
action limit because “no effective, feasible
interventions to reduce BLLs in this range
have been demonstrated.” Maintenance of
high BLLs in chronically exposed children
after intervention emphasizes the need for
primary prevention but does not address the
issue of setting lower action targets. 
Brown and Rhoads (2008) cited the
CDC claim that “given current laboratory
methods, risk for misclassification of chil-
dren is high” for the current BLL of
< 10 µg/dL. To be truthful, they should
have changed “current laboratory methods
to “current screening laboratory practice.”
The CDC-led National Health and
Nutrition Survey study found the accuracy
and reliability of BLL measurements
< 5 µg/dL BLL adequate for describing
national BLL (National Center for Health
Statistics 2008). Potential misclassification
with lower BLL limits is a policy issue, not a
technical one. 
The CDC maintains the old elevated
BLL definition because they have found no
effect threshold; that is, with no effect
threshold, any new action limit would be
arbitrarily defined. An effect threshold did
not determine the 1991 CDC action limit.
Evidence in 1991 suggested that 10 µg/dL
would protect most children from lead
effects (CDC 2005). But it was wrong.
Evidence today points to risk for develop-
mental damage down to the lowest BLLs
explored in prospective studies, effectively
1 µg/dL (Lanphear et al. 2005).
Brown and Rhoads (2008) reserve the
label “lead poisoning” to BLLs > 10 µg/dL.
They propose an action plan on a primary
prevention scale not yet present, requiring
years of legislative and bureaucratic wran-
gling for enaction and implementation. The
proposed interagency partnerships will focus
on “housing where children have repeatedly
been identified as having elevated BLLs,”
without changing the definition of elevated
BLLs to expand the focus below the current
criterion. 
Although there are strong reasons to
promote primary prevention to protect chil-
dren from lead, Brown and Rhoads (2008)
use disingenuous opinion favoring an
incomplete, flawed plan that guarantees
long delays. Waiting years to implement a
new primary prevention plan and neglecting
the majority of exposed children is indefen-
sible. The CDC must redefine the standard,
providing a benchmark by which to judge
further progress and redirecting the focus to
all those affected. At present, scientific evi-
dence supports revising that standard to well
below 5 µg/dL. How unfortunate for our
children that political will supports only
more delay and denial.
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Rothenberg states that the level of concern for
blood lead in children should be lowered from
10 µg/dL, but he provides little cogent ratio-
nale for doing so. As basic science support, he
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to a 3 µM solution of lead (Ishihara et al.
1995), a concentration that is 5,000 times the
plasma levels expected in a child with a blood
lead level (BLL) of 5 µg/dL (Manton et al.
2001); b) a study of squirrel monkeys exposed
in utero to maternal BLLs in the 20- to
70-µg/dL range (Newland et al. 1996); and
c) a study of occupationally exposed workers
with a median BLL of 17.1 µg/dL that con-
tains no data on neurologic effects of lead
(Murata et al. 2003). Rothenberg’s choice of
these citations emphasizes how little basic sci-
ence work has been done on neuro-
developmental effects at the very low levels of
lead under discussion. 
There was a 90% decrease in U.S. child-
hood BLLs from the late 1970s to the late
1990s (Pirkle et al. 1994). If the regression
coefficients relating BLLs < 10 µg/dL to cog-
nitive functions are taken at face value, they
predict a population-wide, half standard
deviation of cognitive improvement as a
result of this fall in blood lead—a remarkable
shift that should have substantially increased
the number of very bright students with IQ
> 135. To our knowledge, no such effect has
been noted in the education literature, nor is
it evidenced, for instance, among the increas-
ing proportion of U.S. students admitted to
U.S. graduate programs (Basken 2006).
What measures can be used to look more
formally for this IQ improvement? IQ itself is
problematic because the Flynn effect and
adjustments in test instruments make secular
changes in IQ hard to interpret. The teaching
content in science and math has likely shifted
over this period. Therefore, in our editorial
(Brown and Rhoads 2008) we cited reading
scores that measure a key skill that has been
identified repeatedly as being affected by lead
exposure among other factors. Campbell
et al. (2000) reported that reading scores,
examined with a suitable time lag in large
nationally representative samples of children,
were virtually unchanged over the critical
period of declining lead levels. Rothenberg is
correct that modest gains in math and science
were recorded, but these changes could easily
have other explanations, and they do nothing
to explain the absence of any signal in reading
scores. Although there may be other expla-
nations for this absence, the simplest expla-
nation of this paradox is that the published
regression coefficients relating BLLs
< 10 µg/dL to cognitive measures, all of
which come from observational studies, are
biased. This possibility is suggested by the
steepening of the IQ curve at low lead levels
[Centers for Disease Control and Prevention
(CDC) 2005b].
Regardless of one’s view of the above evi-
dence, it is important to recognize that virtu-
ally all of the progress made in eliminating
childhood lead poisoning has been through
primary prevention—the control or elimina-
tion of lead sources before children are
exposed. This approach has lowered the pro-
portion of 1- to 5-year-old children with
BLLs > 10 µg/dL from well above 50%
30 years ago to 1.6% in 1999–2002 (CDC
2005a). The percentage is almost certainly
lower today. Primary prevention has been
proven to work and deserves the continuing
attention that we described in our editorial
(Brown and Rhoads 2008). Primary preven-
tion can, and should, include increased
attention to controlling exposures from lead
paint hazards, imported foods, medicines,
cosmetics, and toys. Renewed emphasis on
screening with a lower BLL of concern
would be expensive, intrusive to families,
and hard to justify in the absence of proven,
practical strategies for reducing lead levels in
identified children. Further, it would likely
deflect needed resources away from the pri-
mary prevention effort. 
The CDC, in collaboration with fed-
eral, state, and local agencies, has outlined
and begun to implement a comprehensive,
society-wide effort to prevent lead exposure
in children while maintaining efforts to iden-
tify and treat children with elevated BLLs
(CDC 2005b). The CDC has also developed
specific recommendations for health care and
social service providers, scientists, and public
health practitioners who are interested in
actively participating in these primary pre-
vention efforts by providing valuable leader-
ship and expertise (Binns et al. 2007; CDC
2005b). By working together with federal,
state, and local agencies to foster expansion
of primary prevention services, these child
advocates can accelerate achieving our
mutual goal—lead-safe environments for
the nation’s children. 
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